Lazaridis K N, Pham L, Vroman B, de Groen P C, LaRusso N F
Center for Basic Research in Digestive Diseases, Mayo Clinic and Foundation, Mayo Medical School, Fochester, Minnesota 55905, USA.
Am J Physiol. 1997 May;272(5 Pt 1):G1168-74. doi: 10.1152/ajpgi.1997.272.5.G1168.
While previous work has demonstrated that monosaccharides can be absorbed from bile, studies of sugar transport by the biliary, epithelia (i.e., cholangiocytes) are lacking. Using a novel model of polarized rat cholangiocytes in primary culture, designated normal rat cholangiocytes (NRC), we examined directly the uptake and transcellular transport of a nonmetabolizable monosaccharide, methyl alpha-D-glucopyranoside (AMG). When the apical or basolateral domain of cholangiocytes was exposed to radiolabeled AMG or sucrose (control), only apical absorption of AMG was evident. This apical uptake was time dependent, saturable, and significantly inhibited (> or = 90%) by removal of Na+ or in the presence of phlorizin (0.1 mM), a competitive inhibitor of the Na(+)-glucose cotransporter. The transcellular flux of AMG was also polar (i.e., apical to basolateral). Reverse transcriptase-polymerase chain reaction (RT-PCR) revealed the presence of the transcript for the specific Na(+)-glucose cotransporter SGLT1 in NRC and in freshly isolated cholangiocytes but not in purified hepatocytes; in contrast, the transcript for SGLT2 was absent in all liver samples. In situ RT-PCR on frozen sections of normal rat liver showed that SGLT1 was expressed exclusively in cholangiocytes. Immunoblot analysis using a specific polyclonal antibody for the facilitative glucose transporter GLUT1 demonstrated it to be present in vesicles derived from NRC enriched in basolateral plasma membrane domains. Our data are consistent with the concept that SGLT1 is present on the apical domain of biliary epithelia and, in conjunction with GLUT1 on the basolateral domain, accounts for glucose absorption from bile.
虽然先前的研究表明单糖可从胆汁中吸收,但关于胆汁上皮细胞(即胆管细胞)对糖的转运研究却很缺乏。我们使用一种新的原代培养极化大鼠胆管细胞模型,即正常大鼠胆管细胞(NRC),直接检测了一种不可代谢的单糖α-D-甲基吡喃葡萄糖苷(AMG)的摄取和跨细胞转运。当胆管细胞的顶端或基底外侧结构域暴露于放射性标记的AMG或蔗糖(对照)时,仅顶端对AMG的吸收明显。这种顶端摄取是时间依赖性的、可饱和的,并且通过去除Na+或在根皮苷(0.1 mM)存在下显著受到抑制(≥90%),根皮苷是Na(+)-葡萄糖共转运蛋白的竞争性抑制剂。AMG的跨细胞通量也是极性的(即从顶端到基底外侧)。逆转录聚合酶链反应(RT-PCR)显示在NRC和新鲜分离的胆管细胞中存在特异性Na(+)-葡萄糖共转运蛋白SGLT1的转录本,但在纯化的肝细胞中不存在;相反,所有肝脏样本中均不存在SGLT2的转录本。正常大鼠肝脏冰冻切片的原位RT-PCR显示SGLT1仅在胆管细胞中表达。使用针对易化葡萄糖转运蛋白GLUT1的特异性多克隆抗体进行的免疫印迹分析表明,它存在于富含基底外侧质膜结构域的NRC来源的囊泡中。我们的数据与以下概念一致,即SGLT1存在于胆汁上皮细胞的顶端结构域,并与基底外侧结构域的GLUT1一起,负责从胆汁中吸收葡萄糖。